From: Fibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomas
 | N | Fibulin-4 mRNA | P |
---|---|---|---|
Control | 40 | 0.0089 ± 0.0047 |  |
Benign | 60 | 0.0092 ± 0.0054 | >0.05 |
Pathology type | Â | Â | >0.05 |
Serous cystadenoma | 25 | 0.0091 ± 0.0058 |  |
Mucinous cystadenoma | 22 | 0.0098 ± 0.0067 |  |
Endometrioid tumor | 13 | 0.0084 ± 0.0035 |  |
Carcinoma | 16 | 0.0947 ± 0.0083 | <0.05 |
Pathology type | 0 | Â | >0.05 |
Serous cystadenocarcinoma | 58 | 0.0872 ± 0.0097 |  |
Mucinous cystadenocarcinoma | 56 | 0.0913 ± 0.0108 |  |
Endometrioid carcinoma | 46 | 0.0894 ± 0.0087 |  |
Cell differentiation | Â | Â | <0.05 |
High and Medium | 88 | 0.0257 ± 0.0084 |  |
Low | 72 | 0.0968 ± 0.0113 |  |
Tumor stage | Â | Â | <0.05 |
Low stage | 74 | 0.0284 ± 0.0075 |  |
High stage | 86 | 0.0895 ± 0.0118 |  |
Nodal status | Â | Â | <0.05 |
Positive | 83 | 0.0983 ± 0.0094 |  |
Negative | 77 | 0.0309 ± 0.0081 |  |